Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 263

    1.

    Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans.

    Adkins A, Basu R, Persson M, Dicke B, Shah P, Vella A, Schwenk WF, Rizza R.

    Diabetes. 2003 Sep;52(9):2213-20.PMID: 12941759 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.

    Boden G, Cheung P, Stein TP, Kresge K, Mozzoli M.

    Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E12-9.PMID: 12067837 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.

    Roden M, Stingl H, Chandramouli V, Schumann WC, Hofer A, Landau BR, Nowotny P, Waldhäusl W, Shulman GI.

    Diabetes. 2000 May;49(5):701-7.PMID: 10905476 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes.

    Kishore P, Gabriely I, Cui MH, Di Vito J, Gajavelli S, Hwang JH, Shamoon H.

    Diabetes. 2006 Mar;55(3):659-66.PMID: 16505228 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.

    Giaccari A, Morviducci L, Pastore L, Zorretta D, Sbraccia P, Maroccia E, Buongiorno A, Tamburrano G.

    Diabetologia. 1998 Mar;41(3):307-14.PMID: 9541171 [PubMed - indexed for MEDLINE]Related articles

    9.

    Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles.

    Vella A, Reed AS, Charkoudian N, Shah P, Basu R, Basu A, Joyner MJ, Rizza RA.

    Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E25-30. Epub 2003 Mar 11.PMID: 12637258 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.

    Basu R, Shah P, Basu A, Norby B, Dicke B, Chandramouli V, Cohen O, Landau BR, Rizza RA.

    Diabetes. 2008 Jan;57(1):24-31. Epub 2007 Oct 3.PMID: 17914032 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans.

    Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA.

    Diabetes. 2002 Feb;51(2):301-10.PMID: 11812736 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans.

    Dufour S, Lebon V, Shulman GI, Petersen KF.

    Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E231-5. Epub 2009 May 19.PMID: 19458062 [PubMed - indexed for MEDLINE]Related articles

    13.

    Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.

    Nielsen MF, Wise S, Dinneen SF, Schwenk WF, Basu A, Rizza RA.

    Diabetes. 1997 Dec;46(12):2007-16.PMID: 9392488 [PubMed - indexed for MEDLINE]Related articles

    14.

    Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.

    Gosmanov NR, Szoke E, Israelian Z, Smith T, Cryer PE, Gerich JE, Meyer C.

    Diabetes Care. 2005 May;28(5):1124-31.PMID: 15855577 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects.

    Paquot N, Schneiter P, Jéquier E, Gaillard R, Lefèbvre PJ, Scheen A, Tappy L.

    Diabetologia. 1996 May;39(5):580-6.PMID: 8739918 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.

    Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA.

    Diabetes. 2001 Mar;50(3):565-72.PMID: 11246876 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.

    Mevorach M, Giacca A, Aharon Y, Hawkins M, Shamoon H, Rossetti L.

    J Clin Invest. 1998 Aug 15;102(4):744-53.PMID: 9710443 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of acute insulin excess and deficiency on gluconeogenesis and glycogenolysis in type 1 diabetes.

    Boden G, Cheung P, Homko C.

    Diabetes. 2003 Jan;52(1):133-7.PMID: 12502503 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.

    Bock G, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Chandramouli V, Landau BR, Rizza RA.

    Diabetes. 2007 Jun;56(6):1703-11. Epub 2007 Mar 23.PMID: 17384334 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans.

    Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA.

    Am J Physiol Endocrinol Metab. 2002 Aug;283(2):E259-66.PMID: 12110530 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data